We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

036570:KRXNCSOFT Corporation Analysis

Data as of 2026-03-15 - not real-time

₩228,500.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

NCSOFT’s shares are trading at KRW 228,500, comfortably above the 20‑day (≈219k) and 50‑day (≈222k) SMA levels, indicating short‑term bullish momentum. The MACD histogram is positive and the signal line has turned bullish, while the RSI sits at a neutral 55, suggesting no immediate overbought pressure. Volatility over the past 30 days is elevated at roughly 65 %, but the beta of 0.26 points to limited systematic risk. Technical analysis therefore paints a picture of a stock with upward price bias yet subject to sharp intra‑day swings. The current price sits midway between the identified support at ≈195k and resistance near 250k, leaving room for further movement. Recent earnings commentary highlighted robust mobile revenue and strong AION 2 billings, providing a fresh growth catalyst.
Fundamentally, the company posted a 10 % YoY revenue decline, and operating margin is slightly negative, but operating cash flow remains healthy at over KRW 1.5 trillion, underscoring strong cash generation. With a net cash position that far exceeds its KRW 360 billion debt, balance‑sheet risk is minimal. The forward P/E of 13.2 is well below the industry average of 17.8, indicating relative cheapness on a earnings basis. Conversely, the discounted cash‑flow model values the firm around KRW 183 k, notably lower than the market price, flagging a potential overvaluation. The dividend yield of 0.5 % is modest, but the payout ratio of just 8 % of earnings suggests sustainability. Overall, the blend of solid cash flow, modest valuation multiples, and a steady dividend supports a cautiously optimistic outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price trading above short‑term SMAs
  • MACD bullish crossover
  • high 30‑day volatility near resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • strong operating cash flow and free cash flow
  • low debt‑to‑cash ratio
  • sustained dividend payout

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • robust cash reserves supporting strategic investments
  • forward P/E below industry average
  • dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth-10.40%
Profit Margin22.59%
P/E Ratio13.2
ROE10.43%
ROA-1.87%
Debt/Equity10.50
Op. Cash Flow₩151.4B
Free Cash Flow₩136.3B
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI55.1
Support₩194,900.00
Resistance₩250,000.00
MA 20₩219,030.00
MA 50₩221,762.00
MA 200₩206,335.50
MACDBullish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value₩182,787.71
Target Price₩272,208.34
Upside/Downside19.13%
GradeOvervalued
TypeBlend
Dividend Yield0.50%

Risk Assessment

Beta0.26
Volatility65.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.